Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9172 |
High Similarity |
NPD8166 |
Discontinued |
0.85 |
High Similarity |
NPD8127 |
Discontinued |
0.8101 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.8052 |
Intermediate Similarity |
NPD7003 |
Approved |
0.8035 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD6273 |
Approved |
0.8024 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7965 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7935 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.784 |
Intermediate Similarity |
NPD37 |
Approved |
0.7821 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7805 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7805 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7805 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7765 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7716 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7707 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7644 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7644 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7632 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7632 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7616 |
Intermediate Similarity |
NPD7095 |
Approved |
0.76 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7582 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7582 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7572 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7562 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7547 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7544 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7529 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7516 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.747 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7452 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7414 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7412 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7403 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.74 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7386 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7381 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7365 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7351 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7349 |
Intermediate Similarity |
NPD6677 |
Suspended |
0.7348 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7314 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7297 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7296 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7296 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7267 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7262 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7262 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7246 |
Intermediate Similarity |
NPD6873 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7235 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD7680 |
Approved |
0.723 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7226 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7225 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7207 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7204 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7197 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7195 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7186 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7181 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7176 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7172 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.717 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD1653 |
Approved |
0.716 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7153 |
Intermediate Similarity |
NPD228 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7125 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7118 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7095 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7089 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7086 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7079 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD7157 |
Approved |
0.707 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7052 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7051 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7035 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7019 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7019 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7019 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7019 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7013 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD2488 |
Approved |
0.7011 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7011 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7007 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD5585 |
Approved |
0.6989 |
Remote Similarity |
NPD27 |
Approved |
0.6989 |
Remote Similarity |
NPD2489 |
Approved |
0.6988 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD1933 |
Approved |
0.6974 |
Remote Similarity |
NPD3092 |
Approved |
0.6968 |
Remote Similarity |
NPD5647 |
Approved |
0.6968 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD7239 |
Suspended |
0.6963 |
Remote Similarity |
NPD7497 |
Discontinued |
0.6959 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6957 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6957 |
Remote Similarity |
NPD3748 |
Approved |
0.6954 |
Remote Similarity |
NPD1778 |
Approved |
0.6944 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6944 |
Remote Similarity |
NPD7039 |
Approved |
0.6944 |
Remote Similarity |
NPD7038 |
Approved |
0.6943 |
Remote Similarity |
NPD7008 |
Discontinued |
0.6941 |
Remote Similarity |
NPD7411 |
Suspended |
0.6937 |
Remote Similarity |
NPD6353 |
Approved |
0.6936 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD5958 |
Discontinued |
0.6933 |
Remote Similarity |
NPD3091 |
Approved |
0.6932 |
Remote Similarity |
NPD8051 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD1511 |
Approved |
0.6928 |
Remote Similarity |
NPD3972 |
Approved |
0.6928 |
Remote Similarity |
NPD1608 |
Approved |
0.6923 |
Remote Similarity |
NPD3226 |
Approved |
0.6919 |
Remote Similarity |
NPD5402 |
Approved |
0.6914 |
Remote Similarity |
NPD4477 |
Approved |
0.6914 |
Remote Similarity |
NPD4476 |
Approved |
0.6908 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6905 |
Remote Similarity |
NPD5403 |
Approved |
0.6903 |
Remote Similarity |
NPD3266 |
Approved |
0.6903 |
Remote Similarity |
NPD3267 |
Approved |
0.6899 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD7985 |
Registered |
0.6897 |
Remote Similarity |
NPD3021 |
Approved |
0.6897 |
Remote Similarity |
NPD3022 |
Approved |
0.6886 |
Remote Similarity |
NPD2532 |
Approved |
0.6886 |
Remote Similarity |
NPD2534 |
Approved |
0.6886 |
Remote Similarity |
NPD2533 |
Approved |
0.6883 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6879 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6875 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6875 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD1358 |
Approved |
0.6875
|
Remote Similarity |
NPD3787 |
Discontinued |